In this study, we proposed a 3-gene signature, comprising two cellular molecules (CDH4 and STAT4) and one viral oncoprotein (LMP1), for early detection and differentiating advanced stage of NPC with biopsy samples. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.